Integrin-Mediated Drug Resistance in Multiple Myeloma

Drug resistance remains a major obstacle to the treatment of many hematopoietic malignancies such as multiple myeloma. Although much research has been focused on acquired resistance phenotypes, we believe that de navo drug resistance mechanisms may be an important component in protecting cells from...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Leukemia & lymphoma 2000-06, Vol.38 (1-2), p.71-81
Hauptverfasser:	Damiano, Jason S., Dalton, William S.
Format:	Artikel
Sprache:	eng
Schlagworte:	Cell Adhesion drug resistance Drug Resistance, Neoplasm Humans integrins Integrins - metabolism Multiple Myeloma - drug therapy Multiple Myeloma - metabolism Multiple Myeloma - pathology myeloma
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!